List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 8 studies with search of:   "Oprelvekin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Phase II Study of IL-11 (Neumega) in Von Willebrand Disease
Condition: Von Willebrand Disease
Interventions: Drug: recombinant interleukin-11;   Drug: recombinant interleukin-11;   Drug: recombinant interleukin-11
2 Recruiting IL-11 in Adults With Von Willebrand Disease Undergoing Surgery
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
3 Recruiting IL-11 in Women With Von Willebrand Disease and Refractory Menorrhagia
Condition: Von Willebrand Disease
Intervention: Drug: Neumega (Oprelvekin, Interleukin 11, IL-11)
4 Completed Study Evaluating rhIL-11 in Active Crohn’s Disease
Conditions: Crohn Disease;   Inflammatory Bowel Disease
Intervention: Drug: Recombinant Human Interleukin-11 (rhIL-11)
5 Active, not recruiting Interleukin 11, Thrombocytopenia, CML, Imatinib in CML Patients
Conditions: Leukemia;   Chronic Myelogenous Leukemia;   CML
Intervention: Drug: IL-11 (Neumega)
6 Active, not recruiting Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors
Conditions: Breast Cancer;   Gestational Trophoblastic Tumor;   Kidney Cancer;   Lymphoma;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell Tumor
Interventions: Drug: filgrastim;   Drug: recombinant interleukin-11
7 Terminated Study Evaluating rhIL-11 in Left-Sided Ulcerative Colitis
Conditions: Ulcerative Colitis;   Inflammatory Bowel Disease
Intervention: Drug: rhIL-11
8 Recruiting Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Drug: filgrastim;   Drug: recombinant interleukin-11;   Drug: rituximab;   Drug: yttrium Y 90 ibritumomab tiuxetan

  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services